Solid Biosciences Inc. (SLDB)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SLDB
See up to 3 months of SLDB. The 7-day demo opens the 1M and 3M ranges and puts SLDB on your watchlist.
Start 7-day demoLatest SLDB insider trades
About Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc. files with the SEC under CIK 0001707502 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
SLDB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 2 | 6,880 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SLDB insider transactions (Form 4)
4770 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Ian F. Smith - Director | Option exercise | Common Stock | 3,440 | - footnote F1 | - | |
| Ian F. Smith - Director | Option exercise | Restricted Stock Units | 3,440 | $0.00 | - | |
| ||||||
| Ian F. Smith | Option exercise | Common Stock | 3,440 | - footnote F1 | - | |
| Ian F. Smith | Option exercise | Restricted Stock Units | 3,440 | $0.00 | - | |
| ||||||
| Sukumar Nagendran | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| Ian F. Smith | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| Ilan Ganot | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| PERCEPTIVE ADVISORS LLC | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
 Georgia Keresty | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| Martin I. Freed | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| Clare Kahn | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| Lynne Marie Sullivan | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| Adam Leo Stone | Grant or award | Director Stock Option (Right to Buy) | 77,500 | $0.00 | - | |
| David T. Howton - Officer | Grant or award | Restricted Stock Units | 79,341 | $0.00 | - | |
| Gabriel Brooks - Officer | Grant or award | Restricted Stock Units | 58,847 | $0.00 | - | |
| Alexander Cumbo - Officer | Grant or award | Restricted Stock Units | 169,401 | $0.00 | - | |
| Paul Herzich - Officer | Grant or award | Restricted Stock Units | 54,925 | $0.00 | - | |
| Kevin Tan - Officer | Grant or award | Restricted Stock Units | 56,647 | $0.00 | - | |
| Jessie Hanrahan - Officer | Grant or award | Restricted Stock Units | 54,925 | $0.00 | - | |
| Ian F. Smith | Option exercise | Common Stock | 3,441 | - footnote F1 | - | |
| Ian F. Smith | Option exercise | Restricted Stock Units | 3,441 | $0.00 | - | |
| ||||||
| PERCEPTIVE ADVISORS LLC | Grant or award | Pre-Funded Warrant (right to buy) | 8,912,655 | $5.61 | $49.99M | |
| Alexander Cumbo - Officer | Option exercise | Common Stock | 30,031 | - footnote F1 | - | |
| Alexander Cumbo - Officer | Open-market sale | Common Stock | 16,644 footnote F2 | $5.82 footnote F3 | $97K | |
| Alexander Cumbo - Officer | Option exercise | Restricted Stock Units | 30,031 | $0.00 | - | |
| ||||||
| Jessie Hanrahan - Officer | Option exercise | Common Stock | 8,125 | - footnote F1 | - | |
| Jessie Hanrahan - Officer | Open-market sale | Common Stock | 4,134 footnote F2 | $5.82 footnote F3 | $24K | |
| Jessie Hanrahan - Officer | Option exercise | Restricted Stock Units | 8,125 | $0.00 | - | |
| ||||||
| Ilan Ganot | Option exercise | Common Stock | 4,861 | - footnote F1 | - | |
| Ilan Ganot | Open-market sale | Common Stock | 2,658 footnote F3 | $5.82 footnote F4 | $15K | |
| Ilan Ganot | Option exercise | Restricted Stock Units | 4,861 | $0.00 | - | |
| ||||||
| Paul Herzich - Officer | Option exercise | Common Stock | 7,187 | - footnote F1 | - | |
| Paul Herzich - Officer | Open-market sale | Common Stock | 3,616 footnote F2 | $5.82 footnote F3 | $21K | |
| Paul Herzich - Officer | Option exercise | Restricted Stock Units | 7,187 | $0.00 | - | |
| ||||||
| David T. Howton - Officer | Option exercise | Common Stock | 14,687 | - footnote F1 | - | |
| David T. Howton - Officer | Open-market sale | Common Stock | 7,469 footnote F2 | $5.82 footnote F3 | $43K | |
| David T. Howton - Officer | Option exercise | Restricted Stock Units | 14,687 | $0.00 | - | |
| ||||||
| Gabriel Brooks - Officer | Option exercise | Common Stock | 10,937 | - footnote F1 | - | |
| Gabriel Brooks - Officer | Open-market sale | Common Stock | 0 footnote F2 | $5.82 footnote F3 | - | |
| Gabriel Brooks - Officer | Option exercise | Restricted Stock Units | 10,937 | $0.00 | - | |
| ||||||
| Kevin Tan - Officer | Option exercise | Common Stock | 10,625 | - footnote F1 | - | |
| Kevin Tan - Officer | Open-market sale | Common Stock | 5,404 footnote F2 | $5.82 footnote F3 | $31K | |
| Kevin Tan - Officer | Option exercise | Restricted Stock Units | 10,625 | $0.00 | - | |
| ||||||
| David T. Howton - Officer | Open-market sale | Common Stock | 18,894 footnote F1 | $6.44 footnote F2 | $122K | |
| ||||||
| Alexander Cumbo - Officer | Open-market sale | Common Stock | 48,913 footnote F1 | $6.44 footnote F2 | $315K | |
| ||||||
| Ilan Ganot | Open-market sale | Common Stock | 7,205 footnote F1 | $6.44 footnote F2 | $46K | |
| ||||||
| Kevin Tan - Officer | Open-market sale | Common Stock | 14,783 footnote F1 | $6.44 footnote F2 | $95K | |
| ||||||
Item 8.01, 9.01
Item 5.07
Item 5.02
Item 7.01, 8.01
SLDB insider trading FAQ
What is the latest insider trade for SLDB?
Solid Biosciences Inc. (SLDB) had 1 insider filing in the last 90 days, with the most recent on 2026-10-06. The full record for SLDB runs to 70 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SLDB stock?
No insider purchases of SLDB were filed in the last 90 days.
How many insiders are selling SLDB stock?
No insider sales of SLDB were filed in the last 90 days. 34 sales are on record for this company.
Where can I see SLDB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SLDB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ian F. Smith view on EDGAR
- - Ian F. Smith view on EDGAR
- - Sukumar Nagendran view on EDGAR
- - Ian F. Smith view on EDGAR
- - Ilan Ganot view on EDGAR
- - PERCEPTIVE ADVISORS LLC view on EDGAR
- - Georgia Keresty view on EDGAR
- - Martin I. Freed view on EDGAR
- - Clare Kahn view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SLDB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SLDB with a 7-day demo
- SLDB on your watchlist
- Every SLDB Form 4 filing on record
- Up to 3 months of SLDB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
